The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15856
StudyName: Eligibility Prostate Cancer NCT02353715
Date of export from the portal: 02.07.2020
Date of Upload / last change: 16.06.2016
License: Creative Commons BY 4.0

----

Description: 
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing; ODM derived from: https://clinicaltrials.gov/show/NCT02353715
